Cargando…
The Risk of Developing Osteosarcoma After Teriparatide Use: A Systematic Review
Teriparatide is a recombinant human parathyroid hormone analog with anabolic mechanism of action utilized in the treatment of osteoporosis with well-established clinical efficacy. Its use is significantly hindered due to label warnings resulting from pre-clinical rat studies demonstrating an increas...
Autores principales: | Abdulelah, Ahmed A, Haddad, Bassem I, Alhajahjeh, Abdulrahman A, AlQirem, Lina M, El-amayreh, Layla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544053/ https://www.ncbi.nlm.nih.gov/pubmed/37791038 http://dx.doi.org/10.2147/ORR.S408718 |
Ejemplares similares
-
Preoperative and intraoperative risk factors for acute kidney injury after hip fracture surgery: a cohort retrospective study
por: Haddad, Bassem I., et al.
Publicado: (2023) -
Predictors of glaucoma knowledge and its risk factors among Jordanian patients with primary open angle glaucoma at a tertiary teaching hospital: A cross-sectional survey
por: Muhsen, Sana’, et al.
Publicado: (2023) -
Teriparatide and Osteosarcoma Risk: History, Science, Elimination of Boxed Warning, and Other Label Updates
por: Krege, John H, et al.
Publicado: (2022) -
Perceived barriers towards the importance and application of medical research: a source of gender disparity among medical undergraduates
por: AlQirem, Lina, et al.
Publicado: (2022) -
Correction: Perceived barriers towards the importance and application of medical research: a source of gender disparity among medical undergraduates
por: AlQirem, Lina, et al.
Publicado: (2022)